Ovarian function recovery in breast cancer patients receiving adjuvant anastrozole treatment: updated results from the phase 3 DATA trial.

Senna W M LammersSandra M E GeurtsKarlijn E P E HermansIrene E G van HellemondAstrid C P SwinkelsCarolien H SmorenburgMaurice J C van der SangenJudith R KroepAafke H HonkoopFranchette W P J van den BerkmortelWilfred K de RoosAlexander L T ImholzIngeborg J H VriensVivianne C G Tjan-Heijnennull null

Published in: Breast cancer research and treatment (2024)

In patients with CIOFF, OFR during treatment with anastrozole was associated with a deterioration in BC outcomes. These findings underscore the importance of adequate ovarian function suppression in this subgroup of patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
phase iii
early stage
clinical trial
prognostic factors
type diabetes
adipose tissue
insulin resistance
deep learning